PDEX Earnings Date & History
Pro-Dex Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:06 PM ET
Pro-Dex Inc
Health Care
- Next earnings date
- Thursday, August 20, 2026
- Reporting session
- Time TBD
- EPS estimate
- $0.68
- Revenue estimate
- $19.6M
PDEX earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, April 30, 2026 | Q3 2026 | $0.63 | $1.20 | +89.8% | $19.9M |
| Thursday, January 29, 2026 | Q2 2026 | $0.60 | $0.66 | +9.7% | $18.7M |
| Thursday, October 30, 2025 | Q1 2026 | $0.51 | $1.40 | +174.5% | $18.5M |
| Thursday, September 4, 2025 | Q4 2025 | $0.48 | $0.36 | -24.9% | $17.5M |
What the market is watching in PDEX's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next PDEX earnings date?
- Pro-Dex Inc is scheduled to report on Thursday, August 20, 2026 (Time TBD). Dates can change until the company confirms them.
- Does PDEX report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for PDEX?
- Consensus EPS for the upcoming quarter is $0.68, on revenue of $19.6M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
PDEX earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.